Connect Biopharma Holdings Ltd Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| IKARIAN CAPITAL, LLC | 02/18/2026 | 4.79 M | $13.50 M | 100.00% | 8.63% |
| BOOTHBAY FUND MANAGEMENT, LLC | 02/17/2026 | 1.23 M | $3.48 M | 100.00% | 2.22% |
| PERCEPTIVE ADVISORS LLC | 02/17/2026 | 792.70 K | $2.24 M | 100.00% | 1.43% |
| BML CAPITAL MANAGEMENT, LLC | 02/03/2026 | 408.89 K | $1.15 M | -67.74% | 0.74% |
| KNOTT DAVID M JR | 02/12/2026 | 200.00 K | $564.00 K | 100.00% | 0.36% |
| RICHMOND BROTHERS, INC. | 02/12/2026 | 173.49 K | $489.23 K | 100.00% | 0.31% |
| IKARIAN CAPITAL, LLC | 02/18/2026 | 144.60 K | $407.77 K | 100.00% | 0.26% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 143.10 K | $403.54 K | -9.54% | 0.26% |
| MARSHALL WACE, LLP | 02/13/2026 | 128.37 K | $362.00 K | 121.21% | 0.23% |
| CITADEL ADVISORS LLC | 02/17/2026 | 99.49 K | $280.57 K | 100.00% | 0.18% |
| JANE STREET GROUP, LLC | 02/12/2026 | 82.23 K | $231.88 K | 100.00% | 0.15% |
| OMERS ADMINISTRATION CORP | 02/13/2026 | 80.81 K | $227.88 K | 100.00% | 0.15% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 71.50 K | $201.64 K | 420.10% | 0.13% |
| KOA WEALTH MANAGEMENT, LLC | 01/29/2026 | 49.60 K | $139.87 K | 0.00% | 0.09% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 47.05 K | $132.68 K | 100.00% | 0.08% |
| ROYAL BANK OF CANADA | 02/17/2026 | 40.40 K | $114.00 K | 100.00% | 0.07% |
| BOOTHBAY FUND MANAGEMENT, LLC | 02/17/2026 | 37.00 K | $104.34 K | 100.00% | 0.07% |
| PERSISTENT ASSET PARTNERS LTD | 02/17/2026 | 26.77 K | $75.50 K | 100.00% | 0.05% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 23.32 K | $65.76 K | 0.00% | 0.04% |
| HRT FINANCIAL LP | 02/12/2026 | 16.79 K | $47.00 K | 60.51% | 0.03% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/17/2026 | 16.50 K | $46.54 K | 100.00% | 0.03% |
| 02/12/2026 | 12.90 K | $36.37 K | 100.00% | 0.02% | |
| MONOGRAPH WEALTH ADVISORS, LLC | 02/13/2026 | 11.13 K | $31.39 K | 0.00% | 0.02% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/17/2026 | 10.45 K | $29.47 K | 100.00% | 0.02% |
| UBS GROUP AG | 01/29/2026 | 3.17 K | $8.93 K | 1,474.63% | 0.01% |
| MORGAN STANLEY | 02/13/2026 | 2.21 K | $6.23 K | 2,109.00% | 0.00% |
| EVERSOURCE WEALTH ADVISORS, LLC | 02/06/2026 | 1.29 K | $3.63 K | -18.58% | 0.00% |
| RHUMBLINE ADVISERS | 02/13/2026 | 780 | $2.20 K | 0.00% | 0.00% |
| JPMORGAN CHASE & CO | 02/11/2026 | 121 | $341 | 0.00% | 0.00% |
| SIMPLEX TRADING, LLC | 02/11/2026 | 98 | $276 | 100.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 02/03/2026 | 6 | $17 | -14.29% | 0.00% |
| CITIGROUP INC | 02/13/2026 | 0 | $0 | -100.00% | 0.00% |
| XTX TOPCO LTD | 02/17/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Connect Biopharma Holdings Ltd institutional Ownership - FAQ's
During the previous two years, 36 institutional investors and hedge funds held shares of Connect Biopharma Holdings Ltd. The most heavily invested institutionals were:
Richmond Brothers, Inc.: 476,584
BML Capital Management, LLC: 408,887
Simplify Asset Management Inc.: 51,475
Persistent Asset Partners Ltd: 50,747
Koa Wealth Management, LLC: 49,600
JANE STREET GROUP, LLC: 39,598
15.26% of Connect Biopharma Holdings Ltd stock is owned by institutional investors.
Institutional investors have bought a total of 9.18 M shares in the last 24 months. This purchase volume represents approximately $24.31 M in transactions.